Medicortex Finland Announces Agreement with Pro-Lab
Medicortex Finland Oy announces that it has entered into an agreement with a Canadian company Pro-Lab Diagnostics Inc. Pro-Lab will be responsible for the regulatory process and registration of the ProbTBI™ brain injury detection kit in Canada and UK. Following a brain injury, the diagnostic test will detect in urine and saliva a unique brain injury biomarker which has been discovered and characterized by Medicortex. The agreement gives Pro-Lab exclusive rights for sales in the UK and Canada from which Medicortex will receive royalties. The agreement between the parties is confidential and no other details about the content of the agreement are disclosed.
Pro-Lab will be responsible for the clinical validation of the kit prior to the commercial launch in the territories. In addition to the licensing agreement, the parties intend to initiate a development collaboration, the details of which are being discussed currently.
“We are very proud that Pro-Lab Diagnostics has chosen to cooperate with us to get ProbTBI™ registered and approved in Canada and the UK. This is a great success for Medicortex as a company, but more importantly this is a big step forward for patients with concussion and Traumatic Brain Injury (TBI) who will greatly benefit from using a novel biomarker in brain injury diagnosis and management,” says Dr. Adrian Harel, Founder and CEO of Medicortex.
“The agreement reinforces Pro-Lab Diagnostics’ commitment to continue explore scientific and technological advances and their application in Diagnostics” says Mr. Robert Rae, CEO & President of Pro-Lab Diagnostics.
There is an enormous global market potential for a biomarker based rapid diagnostic kit for detecting traumatic brain injury (TBI) and concussion because current symptom-based assessment procedures and imaging methods are inadequate for finding diffuse axonal injuries.
About Pro-Lab Diagnostics
Pro-Lab Diagnostics’ (http://www.pro-lab.com/) mission is to provide high quality, cost effective immunodiagnostic products that benefit medical science. This is accomplished through extensive onsite research and development, leading to the manufacture of high quality and cost effective immunodiagnostic reagents.
Additionally, Pro-Lab Diagnostics distributes a wide array of innovative products sourced from leading companies from around the globe. Disciplines covered include Clinical Microbiology, Molecular Biology, Transfusion Medicine, Instrumentation, Women’s Health and much more. Pro-Lab Diagnostics also specializes in OEM (private label) packaging and welcomes new business opportunities.
About Medicortex
Medicortex Finland Oy (http://www.medicortex.fi) is a biotechnology company dedicated to improving the diagnostics and treatment of Traumatic Brain Injury (TBI). Its current focus is to develop biomarker diagnostics that evaluate the presence of TBI. Once the company completes the development of the diagnostic test its next goal will be to develop an innovative drug to halt the progression of brain injury.
Key words: NFL, ice-hockey, rugby, brain injury, head injury, concussion, diagnostics, TBI, sport, professional athletes, boxing, early detection, military, army, navy, soldier, combat, veteran, trauma, clinical trial
Forward-Looking Statements
This press release contains statements that are "forward-looking statements" that are based upon management's current expectations and assumptions and are subject to a number of risks, uncertainties and other factors that could cause actual results and events to differ materially and adversely from those indicated herein.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180522005889/en/
Contact information
Pro-Lab Diagnostics Inc.
Robert Rae – President & CEO
Tel:
(905) 731-0300 or 1-800-268-2341
Fax: (905) 731-0206
rrae@pro-lab.com
www.pro-lab.com
or
Medicortex
Finland Oy
Dr. Adrian Harel - CEO
Tel. +358 (0) 400
488 817
adrian.harel@medicortex.fi
http://www.medicortex.fi
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Xsolla Redefines the Metaverse With New Metasites Platform for Unreal Creators15.8.2025 19:00:00 EEST | Press release
Xsolla, a global commerce company helping developers launch, grow and monetize their games, announces today the latest evolution of its Metasite™ platform, designed to meet the growing demand for immersive, accessible, and creator-driven Metaverse experiences. Reimagined for Unreal Engine creators, studios, and digital communities, Xsolla Metasite™ offers a seamless, browser-based experience that enables developers and creators to publish, share, and monetize real-time 3D worlds with built-in multiplayer, voice chat, and monetization tools all without requiring downloads, installations, or backend infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250815735499/en/ (Graphic: Xsolla) Powered by advancements in cloud streaming and WebGL, Xsolla Metasite™ is purpose-built for today’s creators and developers seeking a better way to deploy multiplayer experiences, simplify distribution, and activate their audiences. Ke
Xsolla Unveils Cloud Gaming Trials to Convert Game Demos Into Revenue15.8.2025 16:00:00 EEST | Press release
Xsolla, a global commerce company helping developers launch, grow and monetize their games, announces today game trials as a new focus for its Cloud Gaming solution. Designed to help developers and publishers boost visibility, player acquisition, and conversion, the upgraded Cloud Gaming solution bridges the gap between marketing and monetization by enabling instant game access, real-time performance tracking, and flexible pay-to-play models. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250815871365/en/ (Graphic: Xsolla) In an increasingly competitive cloud gaming market projected to surpass $10.4 billion in global revenue by 2025, developers are seeking scalable and cost-effective ways to engage players both before and after launch. With over 19,000 games added to Steam in 2024 alone, visibility and differentiation are more critical than ever. Xsolla’s upgraded Cloud Gaming solution addresses these challenges by offering
SVP Worldwide Announces Global Launch of Three New PFAFF® Sewing Machines: creative expression™ 750, quilt expression™ 725, and expression™ 71515.8.2025 01:33:00 EEST | Press release
SVP Worldwide, the parent company of PFAFF®, SINGER®, and HUSQVARNA® VIKING® sewing brands, today announced the highly anticipated global launch of three new PFAFF sewing machines: the creative expression 750, quilt expression 725, and expression 715. These machines combine precision engineering, cutting-edge technology, and the timeless craftsmanship PFAFF is known for. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250814267636/en/ SVP Worldwide, the parent company of PFAFF (R), launches three new sewing machines: the creative expression 750, quilt expression 725 and expression 715. The machines combine precision engineering, cutting-edge technology, and the timeless craftsmanship PFAFF is known for globally. The new models will be available for purchase beginning August 14, 2025 on PFAFF.com and at authorized PFAFF Dealer locations across the United States and Europe. Expanded global distribution in Latin America and Asia
Rimini Street Awarded U.S. GSA Multiple Award Schedule (MAS) for Oracle, SAP and VMware Support and Security Services14.8.2025 22:49:00 EEST | Press release
Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support, management and innovation solutions, and the leading third-party support provider for Oracle, SAP and VMware software, today announced it has become an approved supplier on the United States General Services Administration’s (GSA) Multiple Award Schedule (MAS) under the contract 47QTCA25D00DT. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250814235551/en/ Rimini Street Awarded U.S. GSA Multiple Award Schedule (MAS) for Oracle, SAP and VMware Support and Security Services The availability of Rimini Street on the GSA expedites federal, state, local and tribal government agencies’ ability to select and switch from costly software vendor support to the Company’s comprehensive support and advanced security services for Oracle, SAP and VMWare at up to a 50% discount compared to the software vendor’s annual maintenance fees. To date, R
Xsolla Expands Payments in the Americas to Boost Conversions With Pay by Bank, Affirm, and Recurring Billing via Mercado Pago14.8.2025 22:00:00 EEST | Press release
Xsolla, a global commerce company helping developers launch, grow and monetize their games, announces today a major expansion of its localized payments offering across North and South America today. With new support for Pay by Bank and Affirm in the United States, Affirm in Canada, and recurring billing via Mercado Pago in Brazil, developers and publishers using Xsolla Pay Station can now unlock new revenue streams, reduce friction, and better connect with players through regionally trusted payment methods. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250814368955/en/ (Graphic: Xsolla) The Americas remain one of the largest and most diverse gaming regions, with a combined market value of approximately USD 100 billion. However, while opportunities are vast, consumer expectations regarding payments vary dramatically by country. Players in the U.S. increasingly seek fast, secure alternatives to credit cards; Canadian gamers a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom